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RESPON TRANSKRIPTOMIK Salmonella enterica Subspecies enterica serovar 
Typhi TERHADAP RAWATAN ANTIBIOTIK  
SEMASA PEMBENTUKAN BIOFILEM 
 
ABSTRAK 
Salmonella Typhi (S. Typhi) ialah patogen khusus manusia yang 
menyebabkan demam tifoid. Satu faktor utama yang menyumbang kepada tifoid 
yang berkekalan adalah dengan kewujudan pembawa tifoid yang tidak bersimptom. 
Pembentukan biofilem dalam pundi hempedu manusia didakwa berkait dengan 
pembangunan pembawa. Tujuan kajian ini adalah untuk membangunkan assai 
pembentukan biofilem S. Typhi secara in vitro yang menyerupai persekitaraan pundi 
hempedu. Enam kunci pembolehubah yang terlibat dalam pembentukan biofilem S. 
Typhi telah dioptimumkan menggunakan Metodologi Respon Permukaan (RSM), 
dan assai yang dihasilkan menjadi asas untuk pengkajian penghasilan biofilem, 
dalam kehadiran antibiotik kanamisin dan kloramfenikol. Kedua-dua sel planktonik 
(bebas renang) dan perantara-biofilem telah dikaji dalam kajian ini bagi menentukan 
corak ekspresi gen yang mempengaruhi komuniti biofilem S. Typhi. Keputusan 
menunjukkan bahawa S. Typhi tidak boleh bermandiri dengan rawatan antibiotik 
tanpa kehadiran biofilem. Bakteria didapati membina biofilem dengan mudah dalam 
kehadiran kanamisin berbanding kloramfenikol. Untuk memperjelaskan mekanisma 
penyesuaian ini, RNA berkualiti tinggi telah diekstrak daripada sampel sel S. Typhi 
planktonik and sel perantara-biofilem yang tidak terawat dan terawat antibiotik. 
Ekspresi gen sel S. Typhi dikelaskan kepada empat kategori: 1) pengawalwaturan 
biofilem, 2) Penghasilan eksopolisakarida dan liposakarida, 3) kerintangan antibiotik, 
dan 4) laluan metabolik. Empat gen yang terlibat dalam biofilem telah dipilih dan 
disahkan menggunakan PCR masa sebenar kualitatif (qPCR). Telah dibuktikan 
 xxi 
 
bahawa gen kerintangan pelbagai-stress telah dikawalatur naik dalam sel perantara-
biofilem dengan rawatan kloramfenikol dan kanamisin. Juga, gen tviD, yang 
diperlukan untuk sintesis antigen Vi telah ditemui dikawalatur turun secara 
signifikan dalam sel planktonik-kanamisin, tetapi tidak pada sel perantara-kanamisin. 
Gen yjfO, yang mengekod untuk stress biofilem dan protein pergerakan telah 
disahkan dikawalatur naik dalam sel perantara-biofilem-kanamisin, tetapi 
dikawalatur turun secara signifikannya dalam sel planktonic-kanamisin. Gen protein 
pengawalatur pembentukan biofilem, bssS telah dikawalatur naik dalam sel 
perantara-biofilem-kanamisin dan dikawalatur turun dalam sel planktonik-kanamisin. 
Diambil bersama, penemuan ini mencadangkan bahawa proses penyesuaian biofilem 
melibatkan peningkatan sintesis eksopolisakarida dan liposakarida untuk pembinaan 
benteng biofilem. Penurunan dalam enzim yang berkaitan dengan aktiviti metabolik 
adalah konsisten dengan penampilan senesen bakteria, membolehkan bakteria 
mengelak daripada sistem imun hos. Kajian ini menyediakan asas untuk pemahaman 
yang lebih baik akan penyesuaian S. Typhi dalam pembentukan biofilem, yang 
membantu bakteria bermandiri dalam stres rawatan antibiotik. Diharapakan, kajian 
ini akan dapat mempelopori dalam pembangunan langkah-langkah terapeutik di masa 
hadapan yang akan dapat menguruskan pembawa dan akhirnya membasmi demam 
tifoid. 
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TRANSCRIPTOMIC RESPONSE OF Salmonella enterica Subspecies enterica 
serovar Typhi TO ANTIBIOTIC TREATMENTS  
DURING BIOFILM FORMATION   
 
ABSTRACT 
Salmonella Typhi (S. Typhi) is a human-specific pathogen which causes 
typhoid fever. One major factor contributing to typhoid persistence is the existence 
of asymptomatic typhoid carriers. Biofilm formation in the human gallbladder is 
postulated to be associated with development of the carrier-state. The aim of this 
study was to develop an optimized assay for S. Typhi biofilm formation in vitro that 
mimics the environment of the gallbladder. Six key variables involved in S. Typhi 
biofilm formation were optimized using Response Surface Methodology (RSM), and 
the resulting assay formed the basis for transcriptomic investigation of biofilm 
production, in the presence of the antibiotics kanamycin and chloramphenicol. Both 
planktonic (free-swimming) and intermediate-biofilm cells were investigated in this 
study, to determine the patterns of gene expression which influence the S. Typhi 
biofilm community. The results showed that S. Typhi could not survive antibiotic 
treatment in the absence of biofilm. The bacteria were found to construct biofilm 
more readily in the presence of kanamycin than chloramphenicol.  To clarify the 
mechanism of this adaptation, high quality RNA was extracted from untreated and 
antibiotic-treated samples of S. Typhi planktonic and intermediate-biofilm cells. 
Transcriptomic analysis was carried out to identify genes responsible for the 
adaptation. Gene expression of S. Typhi cells were grouped into four categories: 1) 
biofilm regulation, 2) exopolysaccharide and lipopolysaccharide production, 3) 
antibiotic resistance, and 4) metabolic pathways. Four genes involved in biofilm 
formation were selected and confirmed using qualitative real-time PCR (qPCR). It 
 xxiii 
 
was established that the Multiple-stress-resistance gene bhsA was up-regulated in the 
intermediate-biofilm cells with chloramphenicol and kanamycin treatments. Also, the 
tviD gene, which is required for synthesis of Vi antigen, was found to be 
significantly down-regulated in the planktonic-kanamycin cells, but not in 
intermediate-kanamycin cells. Gene yjfO, which encodes for biofilm stress and 
motility protein, was confirmed to be up-regulated in the intermediate-biofilm-
kanamycin cells, but significantly down-regulated in planktonic-kanamycin cells. 
Biofilm formation regulatory protein gene, bssS was up-regulated in intermediate-
biofilm-kanamycin cells and down-regulated in planktonic-kanamycin cells.  Taken 
together, these findings may suggest that the biofilm adaptation process involves 
increased synthesis of exopolysaccharides and lipopolysaccharides for the 
construction of the biofilm barrier. The decrease in enzymes associated with 
metabolic activity is consistent with the appearance of bacterial senescence, enabling 
the bacteria to evade the host’s immune system. This study provides a basis for better 
understanding of the adaptability of S. Typhi by means of biofilm formation, which 
enables the bacteria to survive the stress of antibiotic treatment.  It is hoped that this 
will lead to the future development of therapeutic measures that will permit 
management of the carriers and final eradication of typhoid fever. 
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CHAPTER 1.0 
INTRODUCTION 
1.1 Background  
Salmonella enterica subspecies enterica serovar Typhi (S. Typhi) is a 
pathogenic bacterium that causes typhoid fever. Despite major treatment and 
prevention efforts, millions of new typhoid fever infections and thousands of deaths 
occur worldwide each year (Gonzalez-Escobedo et al., 2011). Over the past decade, 
the frequency of antibiotic resistance among S. Typhi isolates has increased 
substantially in endemic regions such as Southeast Asia, Western Asia, Latin 
America, and South and East Africa (Gonzalez-Escobedo et al., 2011; Wong et al., 
2015). S. Typhi is transferred into the human gastrointestinal system by consumption 
of unhygienic food or water. It crosses through the intestinal epithelial layer and 
invades macrophages (specialized cells that combat infections, including 
Salmonella). Macrophages then carry the S. Typhi organisms to the liver, pancreas 
and spleen. There, it is believed that the bacterial cells replicate in both types of cells, 
whether phagocytic or non-phagocytic (McDougald et al., 2012). About 3-5% of 
victims may develop chronic infection and become carriers after the bacteria are shed 
into their gallbladder, where acute infection results. The bacteria interact with bile 
that is produced by the liver in the gallbladder. A moderate acidic environment (pH 
5–6), the toxic effect of bile and the hydrophobicity of gallstones, which are prone to 
develop in hypercholesterolemia patients, provides the perfect harsh conditions for 
the bacteria to form biofilms in the gallbladder.  
 
A study by Kariuki et al., (2010) estimated that almost all S. Typhi isolated 
from acute typhoid patients were resistant to at least one front-line antibiotic. 
2 
 
Further, some 60% were resistant to a range of different antibiotics. It is well-known 
that bile stored in the gallbladder is composed of bile acids, cholesterol, 
phospholipids and bilirubin, which have antimicrobial effects. However, Salmonella 
is able to survive the bactericidal effects of bile (Prouty et al., 2002). Hence, it has 
been proposed that sequestration of S. Typhi in the gallbladder results in persistent 
infection and the typhoid carrier state. The pathogen adapts to sub-lethal 
concentrations of bile by changing its gene expression, leading to biofilm formation 
in the gallbladder and chronic infection of the host (Hernández et al., 2012). Biofilms 
protect bacteria from environmental stresses, including antibiotics and disinfectants. 
These films also provide a barrier that isolates the bacteria from the host’s immune 
system (Castelijn et al., 2012; Robijns et al., 2014) with the result that S. Typhi are 
extremely difficult to eliminate. Around 3-5% of patients who suffer from acute S. 
Typhi infection become carriers; and those with the carrier state frequently have 
gallbladder abnormalities; these may include carcinoma and/or gallstones. 
Approximately 90% of chronically infected carriers have gallstones (Gonzalez-
Escobedo et al., 2011), and 11.1% have been found to have gallbladder cancer with a 
50% mortality rate (Kuba et al., 1998).  
 
Salmonella biofilms are formed on many types of surfaces—whether living 
cells (biotic) or non-living surfaces (abiotic). Stepanovic et al., (2004) studied 
biofilm formation in 122 Salmonella species taken from humans, as well as animals 
and food.  They cultured these on polystyrene plates, and found that all strains could 
form biofilm successfully on the plates. Later studies showed that the amount of 
biofilm produced by Salmonella was dependent on the surface and culture conditions 
(Stepanovic et al., 2004; Steenackers et al., 2012). In line with these studies, it was 
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found that cholesterol-coated polypropylene tubes were good surfaces for biofilm 
formation (Crawford et al., 2008). It was also found that bile was essential for the 
growth of efficient biofilms on the surface of gallstones (Gonzalez-Escobedo et al., 
2011). It is well-established that antibiotic treatments are often not effective against 
S. Typhi in carriers who have gallstones. And Prouty et al., (2002) observed that 
patients who have gallstones are more likely to become typhoid carriers. Since S. 
Typhi is a human-specific pathogen, there is no animal model available. Hence, an in 
vitro biofilm microtiter plate assay may be deemed a useful model for screening of 
biofilm against antibiotics and for understanding the persistence of S. Typhi in 
typhoid carriers.  
 
The human body’s susceptibility to infection has been the focus of most 
studies to date that have considered the effects of antibiotics on biofilm. Utilization 
of streptomycin and vancomycin has increased susceptibility of S. Typhimurium 
infection toward antibiotic treatments (Sekirov et al., 2008). Antibiotics eliminate 
metabolic activities of gut commensals which affect sugars release and bile acids as a 
potential mechanism for antibiotic resistance (Ng et al., 2013; Ferreyra et al., 2014). 
Multiple studies have shown that treatment with high concentrations of antibiotics 
reduces most of the products of bacterial metabolism. These include such things as: 
secondary bile acids, and short-chain fatty acids (Theriot et al., 2014; Jump et al., 
2014). Conversely, bacterial precursors increase when subject to high-dose 
antibiotics. These include primary bile acids, oligosaccharides, and sugar alcohols 
(Yap et al., 2008; Romick-Rosendale et al., 2009; Zhao et al., 2013).  
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Each antibiotic that is used in treating bacteria triggers a particular reaction, 
as can be seen by an analysis of responses of the global bacterial transcriptome (Goh 
et al., 2002; Ng et al., 2003; Lin et al., 2005; Yim et al., 2006). In some cases, the 
physiology of the bacteria reveals that a reflection response has been initiated toward 
the antibiotic, which inhibits bacterial growth. In other cases, however, an adaptive 
response is evident in the bacteria - it becomes resistant, or adaptive, to the antibiotic.  
Ultimately, the use of antibiotics increases the rate of mutation (Alonso et al., 1999; 
Henderson-Begg et al., 2006), as well as the recombination and the horizontal 
transfer of genes (Ubeda et al., 2005; Lopez et al., 2007), and mechanisms by which 
resistance to antibiotics is expressed. In short, a global adaptive response is triggered 
as a result of the stress engendered by antibiotic use.  
 
In this study, chloramphenicol and kanamycin have been used as antibiotic 
treatments for S. Typhi. Chloramphenicol increases the expression of genes involved 
in tRNA biosynthesis. It magnifies the expression of gene translation and vitamin 
biosynthesis, as well as phosphate transport, response to stressors, proton motive 
force, and antibiotic resistance (Maurice et al., 2013). Based on a report by Tezel et 
al., (2016), 76.9% resistance has been observed among Salmonella Infantis strains 
against kanamycin. This study aims to investigate parameters and subsequent 
patterns of gene expression which influence the biofilm community and also, to 
determine the functional mechanisms of chloramphenicol and kanamycin in S. Typhi 
biofilm. 
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1.2 Rationale of the Study 
As new diseases are continually discovered, some diseases which have been a 
problem in the past re-emerge to threaten the human population. This is especially 
dangerous to those who have not previously been exposed to the diseases. One such 
classical example is Salmonella infections. The frequency of antibiotic resistance 
among Salmonella isolates has increased profoundly in regions where the bacterium 
is naturally located. One of the factors that contribute to high salmonellosis 
prevalence is the formation of biofilm in infected patients, making them chronic 
carriers of the Salmonella bacteria which propagate the disease in the population.  
 
Biofilm formation is an important step in bacterial pathogenicity. In biofilm, 
the resistance of the bacteria towards antibiotics increases exponentially. Antibiotics 
will kill the bacteria while it is still in the free-swimming planktonic stage. The 
problem is that the use of antibiotics to treat biofilm in the human body would 
require a cocktail of high dosage antibiotics in the hope of penetrating the 
exopolysaccharide (EPS). Moreover, toxicity due to drug-to-drug interaction during 
the antibiotic treatment is a cause of many deaths, rather than death from the 
bacterial infections. In addition, if antibiotics continue to be used incorrectly, drug-
resistant bacteria strains will continue to proliferate. Hence, the aim of this study was 
to develop an optimized assay for Salmonella Typhi biofilm that mimics the 
environment of the gallbladder as an experimental model for chronic typhoid fever. 
 
It is hypothesized that the typhoid carrier state is associated with S. Typhi 
biofilm formation in the gallbladder. Studies have been conducted regarding the 
significance of antibiotics triggering biofilm formation (Linares et al., 2006, Yim et 
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al., 2007). To date, there has been little conclusive information published that 
provides detail regarding the molecular ecology or the evolutionary dynamic of 
biofilm formation within the human gallbladder. In order to lessen the recurrence of 
future outbreaks of this infection disease, it is vital to gain a greater understanding of 
environmental factors that are involved in its life-cycle, including the persistence, 
growth, and transmission of Salmonella pathogens and the host’s response to 
environmental changes.  
 
In this study, chloramphenicol and kanamycin were chosen as antibiotic 
treatments for their different responses towards S. Typhi biofilm. Chloramphenicol 
effects protein translation through inhibition of the elongation step in the 50S 
ribosome subunit, while kanamycin effects protein translation by tRNA mismatching 
(mistranslation) in the 30S ribosome subunit (Kohanski et al., 2010). Hence, bacteria 
responded differently when chloramphenicol and kanamycin antibiotics were used. 
 
RNA-Seq-based transcriptomic analysis of antibiotic-resistant bacteria has 
been investigated using the Illumina sequencing system. Next-generation sequencing 
method triggered a huge amount of mRNA reads. In transcriptome, the distribution 
associated with reads was mapped randomly through the comparative position along 
the genome for each sample. The two completely sequenced S. Typhi strains which 
are usually used as reference genomes were Ty2 and CT18. Ty2 is commonly used in 
experimentation and vaccine development (Deng et al., 2003). CT18 is a multi-drug 
resistant isolate from Vietnam (Parkhill et al., 2001). Hence, this study used S. Typhi 
CT18 as reference genome and aimed to investigate parameters and subsequent 
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patterns of gene expression which influence biofilm community and the functional 
mechanisms of chloramphenicol and kanamycin on S. Typhi biofilm. 
 
1.3       General Objective 
To evaluate gene expression of S. Typhi planktonic and intermediate-biofilm 
cells with chloramphenicol and kanamycin treatments.  
 
1.4       Specific Objectives 
1. To develop an in vitro S. Typhi biofilm culture using polypropylene 
microtitre plates and Response Surface Methodology. 
2. To determine the growth-curve of S. Typhi cells and antibiotic 
susceptibility for planktonic and intermediate-biofilm cells. 
3. To investigate the effect of chloramphenicol and kanamycin 
treatments on gene expression of S. Typhi cells using Transcriptome. 
4. To evaluate and confirm gene expression of S. Typhi with antibiotic 
treatments using qPCR. 
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Figure 1.1: Flow chart of research experimental overview 
 
S. Typhi cells growth curve for planktonic and intermediate 
biofilm and biofilm cells in 50 ml falcone tubes 
 
S. Typhi strains selection from INFORMM Biobank 
Quality assessment of RNA: quantity, integrity, 
contamination 
 
S. Typhi planktonic and intermediate biofilm cell growth with 
antibiotic treatment 
 
Total-RNA extraction profile from planktonic and 
intermediate biofilm cells 
Up-scaling of planktonic and intermediate biofilm cell culture 
from 96-well microtiter plate to 50 mL falcone tubes 
 
S. Typhi biofilm assay development in polypropylene 
microtiter plates using RSM 
 
Illumina RNA sequencing: library preparation, cluster 
generation, sequencing and data analysis 
Identification of up- and down-regulated genes from 
planktonic and intermediate biofilm cells with antibiotics  
 
Confirmation of gene expression involved with antibiotic 
tretment and biofilm formation in S. Typhi using qPCR 
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CHAPTER 2.0 
Literature Review  
2.1 Salmonella enterica Subspecies enterica serovar Typhi  
The Salmonella serovars that can cause enteric fever in humans include 
Salmonella enterica subspecies enterica serovar Typhi (S. Typhi). This subspecies is 
the agent that causes typhoid fever. Lignieres named Salmonella in 1900, in 
recognition of Daniel Elmer Salmon. He was the bacteriologist who, in 1885, 
isolated Salmonella Choleraesuis (S. Choleraesuis) in pigs (Threlfall and Frost, 
1990). The genus Salmonella is clustered within the family Enterobacteriaceae 
(Chart, 2003). It has well-established identifying characteristics incuding ubiquity, 
Gram-negativity, and general motility with peritrichous flagella. In addition, 
Salmonella is known for its straight-rod shape and being non-encapsulated. 
Salmonella is facultative and non-spore forming (Gray and Fedorka-Cray, 2002; 
Molbak et al., 2006). The bacterium ranges in width from 0.7 to 1.5 μm, and in 
length from 2.0 to 5.0 μm (Holt et al., 1994). It can grow successfully in a range of 
temperatures from 8°C up to 45 °C (Hanes, 2003), and the most favourable pH for 
growth is within 6.5 to 7.5 (Garcia-Del Portillo, 1999). 
 
2.1.1 Nomenclature of Salmonella 
The nomenclature of Salmonella is a complicated process which contains 
more than two thousand serovars and the numbers of identified serovars inceasing 
annually. The Salmonella classification system is based on recommendations by 
CDC (Centers for Disease Control and Prevention) and WHO (World Health 
Organization) for Reference and Research on Salmonella, located at the Pasteur 
Institute, Paris, in France (Su and Chiu, 2007).  According to the Judicial 
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Commission of the International Committee on Systemic Bacteriology, the genus 
Salmonella consists of three species, Salmonella bongori, Salmonella enterica and 
Salmonella subterranean. In addition, Salmonella enterica was divided further, with 
the identification of six subspecies: 1) S. enterica subspecies enterica; 2) S. enterica 
subspecies salamae; 3) S. enterica subspecies arizonae; 4) S. enterica subspecies 
diarizonae; 5) S. enterica subspecies houtenae and 6) S. enterica subspecies indica. 
Serovar strains in subspecies I are mostly clinical pathogen identified before 
serotyping was introduced which include S. Typhi, S. Typhimurium, and S. 
Enteritidis etc. (Table 1.1). 
 
Table 2.1: Nomenclature of Salmonella (adapted from Su and Chiu, 2007) 
Genus 
(italic) 
Species 
(italic) 
Subspecies 
(italic) 
Serovars 
(not italic) 
No of 
Serovars 
Salmonella enterica enterica (subspecies I) 
Choleraesuis, 
Enteritidis, 
Paratyphi, 
Typhi 
1504 
  salamae (subspecies II) 9, 46:z:z39 502 
  arizonae (subspecies IIIa) 43:z29:- 95 
  
diarizonae (subspecies 
IIIb) 
6,7:1, v:1,5,7 333 
  houtenae (subspecies VI) 21 :m, t:- 72 
  indica (subspecies VI) 59:z36:- 13 
Salmonella bongori (subspecies V) 13,22:z39:- 22 
Salmonella subterranean (subspecies VII)   
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2.1.2 Laboratory Identification of Salmonella Typhi 
Presently there are two strategies being practised in the laboratory for 
identification of S. Typhi; the conventional bacterial culture technique and the 
serotyping method. The bacterial culture technique involves less skill but requires 
more steps and is more time-consuming than the serotyping techniques. In order to 
identfy Salmonella accurately the bacterium must be isolated, followed by 
biochemical characterization and serotyping. Isolating Salmonella from clinical 
samples such as stool requires the use of non-selective media for general culture, 
followed by specific culturing in selective media. Alternatively, selective and 
differential media can be used from the outset. The selective differential media that 
are most commonly used to isolate Salmonella are Xylose Lysine Deoxycholate agar 
(XLD) and MacConkey agar (Perilla et al., 2003). Transparent colonies of bacteria 
with a black dot in the center are an indication of the genus Salmonella using XLD 
while colorless colonies of Salmonella grow on MacConkey agar.  
 
Most Salmonella strains are motile, and achieve their effect with the 
fermentation of glucose and the production of acid and gas.  This assists in the 
biochemical characterization of the bacterium. Biochemical tests that are used to 
differentiate bacteria are based on the metabolic activities of the organism, together 
with minor changes in growth conditions. These conditions include such things as 
nutrient concentration, temperature, and pH. Biochemical properties of the 
Salmonella were subjected to the following five tests: Triple Sugar Iron (TSI) 
Medium, Urea Agar Base, Simmons Citrate Agar, Sulphide Indole Motility (SIM) 
Medium, and Methyl Red-Voges Proskauer (MRVP) Medium (Table 1.2).  
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Triple Sugar Iron (TSI) medium is sometimes used by the Food and Drug 
Administration (FDA) as a key to begin the process of identifying enterobacteria. 
The medium consists of three sugars: glucose, lactose and sucrose and it 
differentiates among various types of enteric Gram-negative bacteria based on the 
fermentation of carbohydrate and production of H2S (Vanderzant and Splittstoesser, 
1992). Urea agar is commonly used as an aid to identify enteric Gram-negative 
bacilli based on urea hydrolysis. In a positive test the colour will change due to 
ammonia production, while no colour change will be observed in S. Typhi if urease 
is negative. Another test is performed with Simmons citrate agar, which is used to 
diagnose enteric Gram-negative bacilli. Findings are based on the utilization of 
inorganic ammonium salt as a source of nitrogen, and sodium citrate as a source of 
carbon (Simmons, 1926).  
 
SIM medium combines three tests in a single tube: Indole and H2S production 
and motility (Perilla et al., 2003). A further test can be performed by adding drops of 
Ehrlich’s or Kovac’s reagent to a growth medium. If a purple-red coloration occurs 
this indicates the presence of indole (Harrigan and McCance, 1966), while an acid 
reaction (yellow colour) at the bottom of the medium indicates lack of indole; this 
latter reaction is caused by the fermentation of glucose (Vandeppitte et al., 2003). 
MR-VP Medium is a test that can be used to assist in the differentiation of enteric 
Gram-negative bacilli. MR-VP is based on methyl red and acetylmethylcarbinol 
(Voges-Proskauer) reactions, and determines the ability of the bacterium to convert 
glucose into acidic products including lactate, acetate and formate (Clark and Lubs, 
1915). 
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Table 2.2: Biochemical tests for identification of S. Typhi (adapted from 
WHO,2003) 
Organism 
Triple Sugar Iron Test 
Motility, Indol, Urea 
Test 
Citrate 
Test 
Slant Butt H2S Gas Motility Indol Urea 
S. Typhi Alkaline Acid Wk+ - + - - - 
S. Paratyphi A Alkaline Acid - + + - - - 
Other Salmonella 
spp. 
Alkaline Acid V V + - - V 
‘+’ = Positive; ‘-’ = Negative; Wk+ = Weak positive; V = Variable result 
H2S = Hydrogen sulphide 
 
Serotyping is based on a distinctive antigen-speciﬁc (antibody) response that 
is created by an organism which invades a mammalian host. Proteins and 
polysaccharides are among the bacterial antigens which promote the antibody 
response that is used for serologic classiﬁcation (Riley, 2009). Serotyping is only 
valid on strains that have already been confirmed biochemically to be Salmonella, 
because the counteragent may cross-react with other types of bacteria (Ellermeier 
and Slauch, 2006). The serotyping method provides more a reliable result compared 
to conventional serotyping as the Vi antigen may not be expressed in certain 
laboratory conditions (Wain et al., 2005).  
 
2.2 Overview of Typhoid Fever 
Typhoid fever is a severe disease that can have a major effect on the entire 
human body. In particular, it involves the reticuloendothelial system and gall 
bladder. It is normally indicated by a lengthy fever, abdominal discomfort, malaise, 
headache, constipation, rose-coloured spots on the chest, hepatomegaly and 
splenomegaly. It is caused by Salmonella enterica serovar Typhi. It is usually spread 
by ingestion of water or food that is contaminated and has not been properly treated 
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(Luxemburger and Dutta, 2005). Children and elderly (i.e., those with compromised 
immune systems) are disproportionally affected by the disease, especially among 
populations in parts of Asia (South Central, Southeast), Africa (Southern) and Latin 
America. One Southeast Asian country endemic for typhoid fever is Malaysia. 
According to Ministry of Health records, in 2010 there were two hundred and ten 
reported cases of typhoid fever (Kementerian Kesihatan Malaysia, 2011). 
 
Symptoms of the disease manifest 10 to 14 days post-innoculation and vary 
with geography. The latest WHO report estimated that typhoid fever caused over 21 
million illnesses with 217,000 deaths in 2000 (Crump et al., 2010).  Moreover, The 
CDC estimated that at least 22 million illnesses and 600,000 deaths worldwide were 
attributed to typhoid fever and person-to-person spread of a low, infectious dose of S. 
Typhi (CDC, 2007). Blood antibody titers are highest during the first week, but 
delayed onset or absence altogether of overt symptoms in many patients makes the 
clinical diagnosis of typhoid fever challenging (Parry et al., 2002). In addition, S. 
Typhi is transmitted via the fecal-oral route, yet stool cultures are positive in only 
30% of symptomatic typhoid patients (Parry et al., 2002). A regimen of 
fluoroquinolones such as ciprofloxacin and bed rest were used to treat most cases of 
enteric fever, but the introduction of multi-drug resistant strains in endemic areas is 
making management of the disease particularly problematic. 
 
Over the past decade, high-dose antibiotic therapy has resolved fewer and 
fewer chronic infections, to the point that less than two-thirds of chronic infections 
can be treated, today. The incidence of antibiotic resistance in endemic regions has 
increased dramatically. Currently, resistance to multi-drug treatment is evident in up 
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to 60% of all known strains (Gonzalez-Escobedo et al., 2011). Victims of the disease 
who subsequently become carriers after their recovery from acute illness may be as 
high as 3 to 5 percent of all infections (Gupta et al., 2006). Whether or not a patient 
becomes a carrier, initial infection can be fatal in the immunocompromised, in young 
children, and in the elderly. 
 
2.3 Typhoid Chronic Carriage   
Comprehensive studies during chronic carriage regulatory processes facilitate 
the understanding of what is happening during biofilm development. Salmonella 
enterica subspecies enterica serovar Typhi (S. Typhi) can linger in the human 
carrier’s gallbladder, suggesting that there is a connection between the bacteria and 
individuals with gallbladder abnormalities (Prouty and Gunn, 2003). When S. Typhi 
crosses the epithelial layer of the intestine, it invades macrophages and thence is 
transported to the liver, pancreas and spleen. There, it is thought to replicate, 
regardless of whether the cells are both phagocytic and non-phagocytic (McDougald 
et al., 2012). Bacteria in the liver are sloughed off and move to the gallbladder, shed 
into the intestine and interact with bile.  Bile, in turn, emulsifies lipids which are 
shed in faeces. These contain the bacteria carried by the bile. Salmonella forms 
biofilm to protect itself from the high concentration of bile, which consists of bile 
acids, cholesterol, phospholipids and bilirubin (Prouty et al., 2002).  
 
The carrier state in typhoid patients is frequently connected with those who 
have gallbladder abnormalities, for example gallstones. Approximately, 90% of 
chronically infected carriers have gallstones (Gonzalez-Escobedo et al., 2011). 
Antibiotics prescription is a common and effective method to treat typhoid fever. 
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Only 90% of typhoid patients fully recover from the disease. However, 10% will 
continue to shed the bacteria for up to 3 months, and other 5% become long-term 
carriers without showing any clinical symptoms; yet they will continue shedding 
bacteria in their stools for over a year (Parry et al., 2002; WHO, 2005). The chronic 
carrier stage is characterized by long-term colonization of the bacilli in the 
hepatobiliary system (Gupta et al., 2006). It has been suggested that S. Typhi can 
form biofilms on the gallstones, providing a more permanent habitat (Prouty et al., 
2002) from acute and chronic infection.  
 
Antibiotic treatments are not effective in eliminating bacteria (Figure 2.1) in 
the gallbladder. The infection can seldom be eradicated if the substrate, to which the 
bacterial cells are attached, is not removed. Hence, the only option to get rid of the 
biofilm is by surgically removing the gallstones (Prouty et al., 2002). In many cases, 
removing a biofilm-colonized gallbladder in the case of chronic typhoid infection is 
the only means to address the persistence of typhoid disease (Gonzalez-Escobedo et 
al., 2011). Furthermore, the typical community of bacteria in the biofilm (Figure 2.1) 
is sessile and bound in a matrix. From that biofilm community, intermediate-biofilm 
(free individual) cells fall. In humans, this may cause further infection or lead to the 
release of the bacterium into the environment through faeces or urine (Selander, 
1991). Thus, carriers contribute to transmission of the pathogen in the wider human 
community (Pradier et al., 2000; Olsen, 2001; Esteves et al., 2005). In addition, it 
has been shown that chronic carriers of S. Typhi are seriously in danger of 
developing hepatobiliary carcinomas. In fact, they have an 8.47-fold higher risk of 
developing cancer of the gallbladder (Davey and O'Toole, 2000). 
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Figure 2.1: S. Typhi biofilm community under fluorescence microscope 
 
2.4 Life Cycle of Biofilm Cells 
To an ever-increasing extent during the past twenty years, bacterial biofilms 
have been implicated as a global danger to public safety. Biofilms can be defined as 
disparate communities of microorganisms that cling to one another and also to biotic 
or abiotic substrates (Steenackers et al., 2012). S. Typhi biofilm is grown through a 
complex process that requires transporting microbial cells as well as organic and 
inorganic molecules, to the surface.  
 
In the 1980s, biofilm formation was described in three stages: (1) absorption, 
(2) attachment, and (3) colonisation (Fletcher, 1980). But in the 1990s, biofilm 
formation was outlined as an eight-step process. The steps include, among others, the 
early-stage formation of a layer that provides conditioning, the reversible and 
irreversible adherence of bacteria to the surface (biotic or abiotic), and the eventual 
release of cells from the mature biofilm; these subsequently re-gather to colonize 
afresh and start another attachment (Characklis and Marshal, 1990). In the first 
decade of the 21st century, biofilm formation was discribed in four different stages: 
18 
 
(1) preliminary attachment to a surface, (2) microcolony formation, (3) maturation of 
biofilm, and (4) diffusion and cell death (Russo et al., 2006).  
 
Figure 2.2 shows a schematic representation of S. Typhi biofilm formation 
according to Russo’s description. Before the attachment takes place, S. Typhi 
approaches a solid-liquid interface closely. The motility of S. Typhi tends to slow 
down and establishes a temporary association with other cells on the surface 
(Prakash et al., 2003). Once S. Typhi reaches the surface, flagellated appendages 
such as fimbriae and pilli take over the attachment role. Fimbriae are vital in cell-to-
surface hydrophobicity binding while pilli are important for host-cell colonization 
(Prakash et al., 2003).  
 
In the process to the development of microcolonies, cell-surface interaction is 
not sufficient. A stable cell-cell interaction is also required to hold the microcolony 
(Stanley and Lazazzera, 2004). At this stage, signal transduction is needed for the 
formation of surface motility structures, for example the pilli, and the production of 
exopolysaccharide (EPS), which mediates the stabilization of cell-cell interaction. 
Quorum sensing (QS) is helpful at this stage. S. Typhi secretes the signal molecules 
and when signal molecules reach a threshold, the genes that control EPS production 
will be stimulated (Prakash et al., 2003). These signals are important in adaptation to 
the environment. The maturation of biofilm is regulated by several signals such as 
QS, catabolism repression, and starvation. Studies showed that at this stage, biofilm 
develop properties such as increased antibiotic tolerance, development of EPS, 
increased ability to withstand UV light, and elevated production of secondary 
metabolites. It has been proposed that at this stage pilli within water channels are 
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formed in order to permit nutrients to enter and waste to leave (Danese et al., 2000; 
Stanley and Lazazzera, 2004).  
 
At the dispersion stage, the cells in the biofilm will migrate to become 
planktonic cells. This condition occurs especially when the environment is not 
favourable. The detachment could be triggered by internal factors, for example QS or 
external factors such as the shear forces or nutrient depletion (Donlan, 2002). As yet, 
there is still considerable research to be done to understand the mechanism, the 
function, and the regulation of detachment from the S. Typhi biofilm.  
 
 
 
 
 
Figure 2.2: Life cycle of biofilm cell. The intermediate-biofilm cells are attached on 
a favourable surface and form a microcolony which leads to biofilm 
maturation. Exopolysaccharide is formed surrounding the bacteria during 
biofilm maturation. Dispersion of the cells occurs when there are 
unfavourable conditions involved    
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2.5 Structural Components of Biofilm 
Microbial species operate in various ways, including the mechanism by 
which they manage to come in contact with a surface, attach them to it, and promote 
cell-to-cell communication. Their growth as complex structures also demonstrates 
multiple facets (Wang et al., 2004).  Typically microbes find it easier to adhere to 
rough surfaces, as well as those that exhibit hydrophobic properties, or have 
conditioning films on their surface (Chae et al., 2006). There are several properties 
of the cell’s surface that are important for biofilm formation and development: 
notably EPS production, inter-cell communication, and the existence of extracellular 
appendages (Davies et al., 2003). Other structural components that are important 
during S. Typhi biofilm formation include flagella, curli and other fimbriae, BapA, 
and anionic O-antigen capsule. Cellulose, colonic acid and fatty acids are also 
implicated (Steenackers et al., 2012).  
 
2.5.1 Exopolysaccharide  
Hori and Matumoto (2010) have demonstrated that roughly 50-90% of the 
total organic carbon of biofilms is attributable to EPS. EPS consists of an elaborate 
admixture of biopolymers; this includes polysaccharides, proteins, humic substances, 
nucleic acids, and lipids.  Further, EPS facilitates the introductory attachment of cells 
to various strata, and it protects the cells from dehydration and from environmental 
stress (Vu et al., 2009).  Depending on its structure, EPS may be either hydrophilic 
(water-loving) or hydrophobic (repelled by water) (Donlan, 2002), and yet, EPS 
itself contains in the vicinity of 97% water (Sutherland, 2001; Karatan and Watnick, 
2009). This means that it is highly hydrated. Polysaccharaides are an important 
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element of biofilm matrices. Its chemical and physical properties could vary based on 
the monomer units and also its glycoside linkages (Pamp et al., 2007).  
 
Cellulose is an example of a polysaccharide which is widely described in E. 
coli and Salmonella spp. (Pamp et al., 2007). EPS makes an important contribution 
toward the morphology and internal structure of biofilm, because is dictates 
properties of the biofilm, including physical and chemical aspects. Also, EPS matrix 
acts as a barrier to allow selective transportation. For example, it protects biofilm 
against adverse conditions such as high concentrations of biocides and 
antimicrobials. It also contains molecules that are essential for cell-to-cell 
communication and cellular conduct within the community (Simões et al., 2010). 
EPS forms locally-charged biofilm matrices that appear in three dimensions, and 
have a gel-like appearance. Frequently, when EPS is not present in the biofilm, 
bacteria still attach to the surface but multilayer biofilms are unable to grow (Karatan 
and Watnick, 2009). 
 
2.5.2 Lipopolysaccharide 
Another major constituent of Gram-negative bacteria is lipopolysaccharide 
(LPS) (Rojas et al., 2001). It is an amphiphilic molecule, a lipid- and fat-loving 
molecule (Gronow et al., 2010). LPS is a complex glycolipid which can be divided 
into three regions; lipid A, core polysaccharide and O-polysaccharide which is 
known as O-antigen (Sperandeo et al., 2009). This lipopolysaccharide structure is 
known as ̒smooth lipopolysaccharide ̓ (S-LPS). O-polysaccharide consists of 
repeating units (O-unit) of monomers and a single glycosidic link (Consterton, 2009).  
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In Salmonella, the monomers are galactose, rhamnose, mannose, and 
abequose (Wang et al., 1996). O-polysaccharide forms the surface and forms a 
protective layer. The long chain of O-polysaccharide becomes a virulent factor in 
most bacteria (Consterton, 2009). LPS plays a role in helping to stabilize the 
membrane of Gram-negative bacteria (Gronow et al., 2010).  Besides, it assists with 
the integrity of the outer cell membrane. The characteristics of this component allow 
the outer membrane to act as a barrier to prevent the entry of toxic molecules. The 
length of O-polysaccharide is essential to absorbing the nutrients and it is important 
in resistance to many different detergents and antibiotics (Christie, 2010). 
  
2.6 Planktonic, Intermediate-Biofilm and Biofilm Cells 
Planktonic cells are free-swimming in the absence of stress, whereas biofilm 
cells have adapted in response to bile stress. Biofilms are groups of cells that are 
embedded in a layer of polysaccharide matrices and adhere to the surfaces. 
According to Kiedrowsky and Horswill (2011), intermediate-biofilm cells clump 
together irreversibly and form small aggregates. So far, there is little evidence to 
define the stage at which intermediate-biofilm forms, but microscopy studies on in 
vivo biofilms have provided images confirming the existence of these aggregated cell 
clumps (Stoodley et al., 2008). Based on a report by Kiedrowski & Horswill (2011), 
intermediate-biofilm cells are formed during biofilm microcolony formation. 
However, Chua et al., (2014) proposed that intermediate-biofilm cells are formed in 
the final stage of the biofilm lifecycle (dispersal), and that the process of dispersal 
confers ‘protection-in-advance mechanisms’ to cope with environmental insults. 
Chelvam et al., (2015) measured variable responses to carbon utilization between 
planktonic, induced biofilm (intermediate-biofilm) and biofilm cells of S. Typhi. 
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The current study allows for either of these two views: that intermediate-
biofilm forms during the microcolony formations stage, or during the biofilm 
dispersal stage. When growth conditions are optimal, nutrients are available and in 
the absence of stress planktonic cells are formed. Then, the stress level increases 
(through nutrient depletion, pH and temperature changes, shear forces and 
antibiotics) and during this period the microcolony matures into an established 
biofilm. Therefore, intermediate-biofilm cells are transition cells as they seek to 
adapt to the new environmental stresses before they fully attach to the surface.  
 
Antibiotics may control disease symptoms by eliminating the planktonic 
cells, but neglect those bacteria which are in the inner layers of the biofilm. Once the 
antibiotic treatment stops, the biofilm may act as a platform for revival of the 
disease. Intermediate-biofilm plays a crucial role in this process, as the dispersion of 
biofilm cells allows the disease to persist in the presence of environmental antibiotic 
stimuli. Few studies have considered the effect of antibiotic on intermediate-biofilm. 
Howden et al., (2010) have noted vancomycin resistance at the intermediate-biofilm 
level due to various regulatory mutations that increase cell wall thickness.  
  
2.7 Antibiotics Responses in Salmonella 
 Excessive dose or low dose of antibiotics can have a deleterious effect on 
the human host, as it can lead to collateral damage of microflora within the 
duodenum, or increase the chance of antibiotic resistance in Salmonellosis. 
Increasing the antibiotic concentrations to 5% of total bacterial culture increases 
stress response and decreases transcript modulation, which inhibits the growth of the 
bacteria (Fajardo and Martínez, 2008). In addition, low concentrations of antibiotics 
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could serve as signalling molecules (Linares et al., 2006; Yim and Wang, 2007) 
activating specific bacterial responses. Fajardo and Martínez, (2008) reported that 
such antibiotic-mediated signalling may indeed be initiated by the use of antibiotics 
used therapeutically against the organisms. After they sense the presence of 
antibiotics, the bacteria exhibit complex responses in resistance to that antibiotic. For 
example: Salmonella’s response to antimicrobial mechanisms prompts the 
PhoP/PhoQ mediator to promote survival within macrophages (Prost et al., 2007). 
 
Studies have been conducted to assess the resistance of Salmonella biofilms 
against antibiotics and the repeatability and reproducibility of these assays have been 
reported to be effective for biofilm treatment (Ghasemmahdi et al., 2015). Antibiotic 
resistance observed in biofilm may be due to several predictable mechanisms such as 
efflux pump, low antibiotic doses or slow penetration of antibiotic and pH changes. 
Randall and Woodward (2002) demonstrated that Sequence alignment analysis 
showed the gene oprJ has high similarity to tolC which pumps out bile acids, 
antibiotics, dyes and disinfectants. Moreover, tolC is required for efficient bacteria 
adherence to a surface during biofilm formation (Lee, 2012). Klebsiella pneumonia 
required more than 500 µg/mL of ampicillin to eradicate biofilm (Anderl et al., 
2000). In addition, slow antibiotic penetration may occur due to ionic attraction 
between the antibiotic and the exopolysaccharide of the biofilm, hindering its 
mobility (Prakash et al., 2003). As the oxygen concentration reduces in the inner 
layers of the biofilm, anaerobic acidic niche causes pH changes in the 
microenvironment and deactivates the antibiotics. This leads to survival of the 
biofilm cells (König et al., 1993). For example: kanamycin is only effective when pH 
is at the optimum range of 7-8. 
